CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer
B Xie, J Lin, X Chen, X Zhou, Y Zhang, M Fan, J Xiang… - Molecular Cancer, 2023 - Springer
Abstract Background Bladder cancer (BCa) is the fourth most common malignant tumor with
a poor prognosis worldwide. Further exploration and research are needed to unmask the …
a poor prognosis worldwide. Further exploration and research are needed to unmask the …
The human long non-coding RNA LINC00941 and its modes of action in health and disease
E Morgenstern, M Kretz - Biological Chemistry, 2023 - degruyter.com
Long non-coding RNAs have gained attention in recent years as they were shown to play
crucial roles in the regulation of cellular processes, but the understanding of the exact …
crucial roles in the regulation of cellular processes, but the understanding of the exact …
[HTML][HTML] MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
LA Bravo-Vázquez, N Frías-Reid… - Translational …, 2023 - Elsevier
MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are two relevant classes of non-
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …
LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2
J Wang, Z He, X Liu, J Xu, X Jiang, G Quan… - Cell death & …, 2022 - nature.com
Recently, long non-coding RNAs (lncRNA) have been proven to regulate pancreatic cancer
(PC) progression. We aimed to explore the pathogenesis of LINC00941 in PC regarding …
(PC) progression. We aimed to explore the pathogenesis of LINC00941 in PC regarding …
Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer
Y Huang, W Zhang, Q Li, Z Wang, X Yang - Scientific reports, 2023 - nature.com
Methylation of RNA plays an important role in cancer. Classical forms of such modifications
include N6-methyladenine (m6A), 5-methylcytosine (m5C), and N1-methyladenine (m1A) …
include N6-methyladenine (m6A), 5-methylcytosine (m5C), and N1-methyladenine (m1A) …
Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma
JT Lu, ZY Yan, TX Xu, F Zhao, L Liu, F Li, W Guo - Cell death & disease, 2023 - nature.com
LINC00941 is a novel long noncoding RNA (lncRNA) and emerging as an important factor in
cancer development. However, the exact function and relative regulatory mechanism of …
cancer development. However, the exact function and relative regulatory mechanism of …
Transforming growth factor-beta-regulated LncRNA-MUF promotes invasion by modulating the miR-34a snail1 axis in glioblastoma multiforme
B Shree, S Tripathi, V Sharma - Frontiers in oncology, 2022 - frontiersin.org
Transforming growth factor beta (TGF-β)-regulated long-non-coding RNAs (lncRNAs)
modulate several aspects of tumor development such as proliferation, invasion, metastasis …
modulate several aspects of tumor development such as proliferation, invasion, metastasis …
lncHUB2: aggregated and inferred knowledge about human and mouse lncRNAs
Long non-coding ribonucleic acids (lncRNAs) account for the largest group of non-coding
RNAs. However, knowledge about their function and regulation is limited. lncHUB2 is a web …
RNAs. However, knowledge about their function and regulation is limited. lncHUB2 is a web …
Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β
LJ Chen, L Wu, W Wang, LL Zhai… - International …, 2022 - spandidos-publications.com
Pancreatic cancer (PC) is a lethal type of cancer for which effective therapies are limited.
Long non‑coding RNAs (lncRNAs) represent a critical type of regulator category, mediating …
Long non‑coding RNAs (lncRNAs) represent a critical type of regulator category, mediating …
[HTML][HTML] METTL14 facilitates the metastasis of pancreatic carcinoma by stabilizing LINC00941 in an m6A-IGF2BP2-dependent manner
J Lu, L Yu, N Xie, Y Wu, B Li - Journal of Cancer, 2023 - ncbi.nlm.nih.gov
Pancreatic adenocarcinoma (PC), one of the most fatal diseases, usually generates a poor
prognosis in advanced stages. N6-methyladenosine modification has emerged as a crucial …
prognosis in advanced stages. N6-methyladenosine modification has emerged as a crucial …